Adaptive time management for patients who have non-small cell lung cancer and underwent definitive radiotherapy: a dosimetric study of different gap duration scenarios

References

• Bese NS, Hendry J, Jeremic B. 2007. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys. 68(3):654–661.
   PubMed Web of Science ®Google Scholar
• Brahme A. 1984. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol. 23(5):379–391.
   PubMed Web of Science ®Google Scholar
• Burman C, Kutcher GJ, Emami B, Goitein M. 1991. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 21(1):123–135.
   PubMed Web of Science ®Google Scholar
• Chaikh A, Calugaru V, Bondiau P-Y, Thariat J, Balosso J. 2018. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD indicator to rank modern photon vs proton treatment plans. Int J Radiat Biol. 94(9):789–797.
   PubMed Web of Science ®Google Scholar
• Chen M, Jiang G-L, Fu X-L, Wang L-J, Qian H, Chen G-Y, Zhao S, Liu T-F. 2000. The impact of OTT on outcomes in radiation therapy for non-small cell lung cancer. Lung Cancer. 28(1):11–19.
   PubMed Web of Science ®Google Scholar
• Cox JD, Pajak TF, Asbell S, Russell AH, Pederson J, Byhardt RW, Emami B, Roach M. 1993. Interruptions of high-dose radiation therapy decrease long-term survival of favourable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys. 27(3):493–498.
   PubMed Web of Science ®Google Scholar
• Dale RG, Hendry JH, Jones B, Robertson AG, Deehan C, Sinclair A. 2002. Practical methods for compensating for missed treatment days in radiotherapy, with particular reference to head and neck schedules. Clin Oncol. 14(5):382–393.
   Web of Science ®Google Scholar
• Fowler JF. 2010. 21 Years of biologically effective dose. Br J Radiol. 83(991):554–568.
   Google Scholar
• Fowler JF, Chappell R. 2000. Non-small cell lung tumors repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys. 46(2):516–517.
   PubMed Web of Science ®Google Scholar
• Garau MM, Monné JS, Serés MJC, Binefa CM, Llopis MP. 2009. Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays. Clin Transl Oncol. 11:302–311.
   PubMed Web of Science ®Google Scholar
• González Ferreira JA, Jaén Olasolo J, Azinovic I, Jeremic B. 2015. Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: review of the literature. Rep Pract Oncol Radiother. 20(5):328–339.
   PubMedGoogle Scholar
• Hendry JH, Bentzen SM, Dale RG, Fowler JF, Wheldon TE, Jones B, Munro AJ, Slevin NJ, Robertson AG. 1996. A modelled comparison ofthe effects of using different ways to compensate for missedtreatment days in radiotherapy. Clin Oncol. 8(5):297–307.
   Google Scholar
• Lyman JT. 1985. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl. 104(2s):13–19.
   Google Scholar
• Machtay M, Hsu C, Komaki R, Sause WT, Swann RS, Langer CJ, Byhardt RW, Curran WJ. 2005. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience . Int J Radiat Oncol Biol Phys. 63(3):667–671.
   PubMed Web of Science ®Google Scholar
• Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A. 2010. Use of normal tissue complication probability models in the clinic. Int J Radiation Oncology Biol. Phys. 76(3):10–19.
   PubMed Web of Science ®Google Scholar
• McMillan MT, Ojerholm E, Verma V, Higgins KA, Singhal S, Predina JD, Berman AT, Grover S, Robinson CG, Simone CB. 2017. Radiation treatment time and overall survival in locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 98(5):1142–1152.
   PubMed Web of Science ®Google Scholar
• Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J. 2001. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 49(1):23–33.
   PubMed Web of Science ®Google Scholar
• Mohammed A, Kleefeld C, Moore M, Foley M. 2018. A TCP model for external beam treatment of non-small cell lung cancer. Physica Med. 52:172.
   Google Scholar
• Moiseenko V, Song WY, Mell LK, Bhandare N. 2011. A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy. Radiat Oncol. 6:61.
   PubMed Web of Science ®Google Scholar
• Nahum AE. 1992. Tait DM. Maximising local control by customized dose prescription for pelvic tumors. In: Breit A, editor. Advanced radiation therapy: tumour response monitoring and treatment planning. Heidelberg: Springer; p. 425–431.
   Google Scholar
• Orton CG, Cohen L. 1988. A unified approach TDF and linear quadratic equations. Inr J Radialion Oncology Biol Phys. 14(3):549–556.
   PubMed Web of Science ®Google Scholar
• Pozo G, Pérez-Escutia MA, Ruíz A, Ferrando A, Milanés A, Cabello E, Díaz R, Prado A, Pérez-Regadera JF. 2019. Management of interruptions in radiotherapy treatments: adaptive implementation in high workload sites. Rep Pract Oncol Radiother. 24(2):239–244.
   PubMedGoogle Scholar
• Putora PM, Schmuecking M, Aebersold D, Plasswilm L. 2012. Compensability index for compensation radiotherapy after treatment interruptions. Radiat Oncol. 7:208.
   PubMed Web of Science ®Google Scholar
• Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Gibson D. 1997. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. The Lancet. 350(9072):161–165.
   PubMed Web of Science ®Google Scholar
• Tarnawski R, Fowler J, Skladowski K, Świerniak A, Suwiński R, Maciejewski B, Wygoda A. 2002. How fast is repopulation of tumor cells during the treatment gap? Int J Oncol Biol Phys. 54(1):229–236.
   PubMed Web of Science ®Google Scholar
• The Royal College of Radiologists. 2008. The timely delivery of radical radiotherapy: Standard and guidelines for the management of unscheduled treatment interruptions. 3rd ed. London: The Royal College of Radiologists.
   Google Scholar
• The Royal College of Radiologists. 2019. The timely delivery of radical radiotherapy:guidlines for the management of unscheduled treatment interruptions. 4rd ed. London: The Royal College of Radiologists.
   Google Scholar
• Webb S, Nahum AE. 1993. A model for calculating tumour control probability in radiotherapy including the effects of inkomogeneous distributions of dose and clonogenic cell density. Phy. Med. Biol. 38:652–666.
   Web of Science ®Google Scholar